Advancing future therapeutics

Like you, we are eager to touch down in Boston for the BIO convention.  
Together, let’s explore the possibilities for manufacturing new therapies and vaccines.

June 5-8, 2023 | BIO International 2023 | Boston, MA |  Booth 664

Discover the Resilience Index at BIO International

From a global pandemic in 2020 to a slew of new challenges facing the biopharma industry today, there’s been no shortage of regulatory, economic, and societal headwinds our customers have faced as they work to unlock the next wave of life-saving medicines for patients. 

Cytiva’s biennial Global Biopharma Resilience Index uses survey and qualitative response data to rank biopharma capabilities and resilience across 22 countries, scoring each on five factors critical to meeting global demand for critical medications. This year at BIO, we’ll be sharing the latest 2023 data to examine where the industry has evolved since 2021. 

Learn more about the five key areas of development we believe will help the biopharma industry to continue delivering critical medicines to patients around the world – and where Cytiva is focused on making an impact – and visit us at our booth to get more info on the new data we’ve uncovered.

Meet us at BIO International and discover the 2023 Resilience Index. Book a time today.

2021 Index findings

Talent pool

The biopharma industry depends on a strong pipeline of specialist skills. But in 2021, more than 50% of executives and policymakers said that the rising cost of talent has become increasingly difficult.

We can help with access to purpose-built institutions replicating modern bioprocessing and cell and gene therapy facilities for training and services.

View Cytiva collaboration centers

Strategic relationships help the industry evolve. Entities that nurture their R&D, education, and infrastructure investments are a step ahead, and collaboration will be key to driving a vibrant R&D ecosystem. But just 44% of executives and policymakers stated they believe a widespread culture of cooperation exists in the industry. We can do better. 

Our global Fast Trak™ team delivers high-quality scientific insights, increased proficiency in technical skills, and robust solutions to your challenges in process development and manufacturing. Work with us to gain confidence at every stage of the development process.

Explore Fast Trak™ Bioprocessing Solutions

Manufacturing agility

To respond to capacity needs and establish agile manufacturing practices, we must: deploy manufacturing processes to rapidly scale operations with continuous manufacturing methods; adopt bold technologies; and ensure reproducible results. 

However, executives and policymakers reported that they can meet only 74% of domestic need for critical medications. 

Avoid the capacity crunch

Six in 10 executives said that the era of offshoring drug manufacturing to low-cost countries is over. And 67% said that the manufacturing of biopharma staples such as biologics would dramatically increase in their own countries over the next three years. 

Increasing domestic production while securing stronger networks with suppliers globally offers agility to shore up operations. 

Re-evaluate the supply chain

Government policy and regulation

To deliver life-saving drugs more quickly, biopharma must work in harmony with governments and regulators to accelerate regulatory pathways where appropriate. 

With 65% of executives reporting that their countries are instigating tax or trade policies that help domestic production and R&D, we must work in harmony to improve clarity and collaboration to achieve industry-wide goals.

Collaborate on biomanufacturing capacity

Refining strategies for success

Discover how Cytiva supports the rapidly changing biopharma ecosystem and the ever-advancing future of therapeutics. 

Speed. Innovation. Efficiency. Whatever your strategy, let’s combine our strengths with yours to bring better medicines to life. 

Let’s talk at Booth #664